A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer

NCT02296801 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

307

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer
Breast Carcinoma
Breast Tumors

Interventions

DRUG: Letrozole
DRUG: palbociclib

Sponsor

NSABP Foundation Inc

Collaborators

[object Object]
[object Object]
[object Object]